TIANJIN ZHONG XIN PHARM GROUP
USD 3.20
52W 2.31
3.20 · 62% of range
3.75
Valuation
Market Cap
4.1B
P/E (TTM)
7.6
Div Yield
P/B
2.4
EPS (TTM)
0.42
FCF Yield
12.7%
Growth & Profitability
Revenue
USD 4.9B
-32.7%
5Y CAGR -5.7%
▃ ▄▄▄▇ ▅▁
Net Profit
USD 2.1B
-4.4%
5Y CAGR +26.4%
▁ ▁▁▂▂ ▇▆
Net Margin
43.3%
+12.8 pts
ROE
30.0%
+1.6 pts
Financials
Announcements
Dividends
Buybacks
Corp Actions
Revenue & Profit
Financial Data
| Date | Type | Period | Title | Sentiment |
|---|
Dividend History
| Date | Type | Amount | Currency | Ex-Date | Payment Date |
|---|
Buyback Activity
| Date | Shares | Avg Price | Total ($) | Cumulative |
|---|
| Date | Type | Details |
|---|
TIANJIN ZHONG XIN PHARM GROUP (T14/SI) — FY2025: Revenue CNY 4,917M, Profit 2,131M, EPS 277.0. Data: FY2014-FY2025, Q1, Q2, Q3 quarterly data.
Historical Annual Data (12 years)
| FY | Revenue (M) | Net Profit (M) | EPS | Total Assets (M) | Total Equity (M) |
|---|---|---|---|---|---|
| FY2025 | 4,917 | 2,131 | 277.0 | 11,690 | 7,100 |
| FY2024 | 7,307 | 2,229 | 290.0 | 10,769 | 7,850 |
| FY2023 | - | - | - | 10,230 | 6,652 |
| FY2022 | 8,249 | 862 | 112.0 | 10,157 | 6,582 |
| FY2021 | 6,908 | 769 | 100.0 | 9,067 | 6,546 |